A member of the Medical Development Team since 2017, Rebecca initially focussed on clinical guideline development before moving on to product quality assurance and, more recently, clinical governance.
In her current post she oversees MSI’s annual clinical quality assessment processes including quality technical assistance, clinical audio-visual assessment, and internal quality audits. Rebecca and her team also ensure that all pharmaceuticals and devices used and sold across the partnership are quality assured and meet out minimum standards.
Rebecca holds a master’s degree in Gender, Education, and International Development from University College London and a Professional Certificate in Pharmacoepidemiology and Pharmacovigilance from the London School of Hygiene and Tropical Medicine.
She has a particular interest in the quality and safety of medical products and represents MSI within QUAMED (an organisation focussing on improving access to quality medicines) and the UNFPA’s Quality Assurance of Reproductive Health Products working group. Prior to joining MSI, Rebecca worked on patient-centred health outcome research with Mapi Group, as well as in international IT procurement.